SCHEMBL7348984

SCHEMBL7348984

COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2O)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1S Q13698 10/20 0.79
CYP3A4 P08684 3/20 0.74
TSHR P16473 2/20 0.74
ABCB11 O95342 2/20 0.74
LMNA P02545 2/20 0.74
KCNH2 Q12809 2/20 0.74
SLC22A1 O15245 1/20 0.74
CACNA1F O60840 1/20 0.74
ABCB1 P08183 1/20 0.74
HRH2 P25021 1/20 0.74
ADRA1A P35348 1/20 0.74
SCN1A P35498 1/20 0.74
SCN4A P35499 1/20 0.74
HTT P42858 1/20 0.74
SCN7A Q01118 1/20 0.74
CACNA1D Q01668 1/20 0.74
PLAUR Q03405 1/20 0.74
CACNA1C Q13936 1/20 0.74
SCN5A Q14524 1/20 0.74
SCN9A Q15858 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7348976 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL9385669 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL29376769 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL7273620 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL7264295 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL31567938 0.99 CACNA1S (0.78) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL9722623 0.99 CACNA1S (0.78) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL31567939 0.99 CACNA1S (0.78) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL31567940 0.99 CACNA1S (0.78) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL9722620 0.99 CACNA1S (0.78) CACNA1SCYP3A4TSHRABCB11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250017943-A1 PHARMACEUTICAL COMPOSITION OF DILTIAZEM HYDROCHLORIDE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Auson Pharmaceuticals, Inc. (US) 2025-01-16 US claimed
EP-0702009-A1 Method for the preparation of 3-hydroxy-5-(2-(dimethylamino)-ethy1)-2,3-dihydro-4-(methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds Orion Corporation Fermion (FI) 1996-03-20 EP claimed
EP-0355395-B1 Process for the preparation of intermediates for the synthesis of diltiazem ZAMBON SPA (IT) 1994-03-30 EP claimed
EP-0154895-B1 NEW SULFONIC RESINS HAVING A THERAPEUTICAL ACTIVITY, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ISTITUTO LUSO FARMACO D'ITALIA S.p.A. (IT) 1992-05-06 EP claimed
US-4937334-A Process for the preparation of intermediates for the synthesis of diltiazem ZAMBON GROUP S.P.A. (IT) 1990-06-26 US claimed
US-4587242-A TIME-RELEASE, SULFONATED STYRENE-DIVINYLBENZENE RESINS AND SALTS WITH THE DRUGS INSTITUTO LUSOFARMACO D'ITALIA S.P.A. (IT) 1986-05-06 US claimed
EP-0154895-A2 New sulfonic resins having a therapeutical activity, preparation thereof and pharmaceutical compositions containing them ISTITUTO LUSO FARMACO D'ITALIA S.p.A. (IT) 1985-09-18 EP claimed
JP-2078673-A None JP disclosed
CN-119462561-B Crystal forms of compound, preparation method, bulk drug, composition and application thereof 北京远大九和药业有限公司 2025-04-25 CN disclosed
CN-119837882-A Pharmaceutical composition and preparation method thereof 远大医药(天津)有限公司 2025-04-18 CN disclosed
CN-119462561-A Crystal forms of compound, preparation method, bulk drug, composition and application thereof 北京远大九和药业有限公司 2025-02-18 CN disclosed
US-20250017943-A1 PHARMACEUTICAL COMPOSITION OF DILTIAZEM HYDROCHLORIDE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Auson Pharmaceuticals, Inc. (US) 2025-01-16 US disclosed
US-12102683-B2 Pharmaceutical composition of diltiazem hydrochloride, preparation method therefor, and application thereof AUSON PHARMACEUTICALS INC. (US) 2024-10-01 US disclosed
EP-0128462-B1 NOVEL BENZOTHIAZEPINE DERIVATIVES, PROCESSES FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS Tanabe Seiyaku Co., Ltd. (JP) 1989-03-22 EP disclosed
EP-0158340-B1 NOVEL 1,5-BENZOTHIAZEPINE DERIVATIVE, PROCESSES FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS Tanabe Seiyaku Co., Ltd. (JP) 1989-01-18 EP disclosed
US-4587242-A TIME-RELEASE, SULFONATED STYRENE-DIVINYLBENZENE RESINS AND SALTS WITH THE DRUGS INSTITUTO LUSOFARMACO D'ITALIA S.P.A. (IT) 1986-05-06 US disclosed
US-4547495-A 1,5-Benzothiazepines with cardiovascular utility, and pharmaceutical compositions containing them SCHIAPPARELLI FARMACEUTICI S.P.A. (IT) 1985-10-15 US disclosed
US-4521430-A VASODILATOR, ANTIISCHEMIC AGENT TANABE SEIYAKU CO., LTD. (JP) 1985-06-04 US disclosed
EP-0128462-A1 Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions Tanabe Seiyaku Co., Ltd. (JP) 1984-12-19 EP disclosed
US-4438035-A Method of preparing benzothiazepine derivatives TANABE SEIYAKU CO., LTD. (JP) 1984-03-20 US disclosed